Risk Model for Predicting Survival Outcomes Using Functional Exercise and Patient-Reported Outcomes in Fibrotic Interstitial Lung Disease: A Prospective Observational Study.
Lan-Yan Yang, Hsin-Ting Yang, Yi-Hsuan Yu, Pin-Kuei Fu
{"title":"Risk Model for Predicting Survival Outcomes Using Functional Exercise and Patient-Reported Outcomes in Fibrotic Interstitial Lung Disease: A Prospective Observational Study.","authors":"Lan-Yan Yang, Hsin-Ting Yang, Yi-Hsuan Yu, Pin-Kuei Fu","doi":"10.1111/resp.70076","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Fibrotic interstitial lung disease (F-ILD) has high mortality, necessitating multidimensional staging to assess severity, predict prognosis, and guide treatment. However, the gender-age-physiology (GAP) index lacks patient-reported outcome measures (PROMs) and exercise test parameters, and traditional methods may miss complex variable interactions. The study aimed to develop a risk model of mortality in F-ILD using routine PROMs and exercise test parameters, and to compare the predictive performance with GAP staging system.</p><p><strong>Methods: </strong>Between December 2018 and December 2022, 246 patients from the ILD Prospective Registry with at least 1 year of follow-up (excluding death) were enrolled. Baseline assessments included GAP, 1MSTS, 6MWD, mMRC, SGRQ, and SF36. A tree-based risk model was developed and validated with a 2:1 split. Kaplan-Meier curves and Cox regression were used to estimate survival and hazard ratios, with statistical significance set at p < 0.05.</p><p><strong>Results: </strong>The very-high-risk group (SGRQ > 34.5, 1MSTS < 21) had a significantly higher hazard ratio (HR = 5.13; 95% CI: 2.54-10.35) compared to the non-very-high-risk group. Their 1-, 2-, and 5-year mortality rates were 28.87%, 47.18%, and 82.42%, respectively, similar to GAP stage III but with narrower confidence intervals.</p><p><strong>Conclusion: </strong>This study developed a prognostic model for F-ILD combining PROMs and functional exercise data. The model, which includes the SGRQ, 6MWD, and 1MSTS, outperforms GAP staging, offering benefits like reduced patient fatigue and improved monitoring. Multicenter studies are needed to validate these findings.</p><p><strong>Trial registration: </strong>The study was registered on ClinicalTrials.gov (NCT06476470).</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respirology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/resp.70076","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objective: Fibrotic interstitial lung disease (F-ILD) has high mortality, necessitating multidimensional staging to assess severity, predict prognosis, and guide treatment. However, the gender-age-physiology (GAP) index lacks patient-reported outcome measures (PROMs) and exercise test parameters, and traditional methods may miss complex variable interactions. The study aimed to develop a risk model of mortality in F-ILD using routine PROMs and exercise test parameters, and to compare the predictive performance with GAP staging system.
Methods: Between December 2018 and December 2022, 246 patients from the ILD Prospective Registry with at least 1 year of follow-up (excluding death) were enrolled. Baseline assessments included GAP, 1MSTS, 6MWD, mMRC, SGRQ, and SF36. A tree-based risk model was developed and validated with a 2:1 split. Kaplan-Meier curves and Cox regression were used to estimate survival and hazard ratios, with statistical significance set at p < 0.05.
Results: The very-high-risk group (SGRQ > 34.5, 1MSTS < 21) had a significantly higher hazard ratio (HR = 5.13; 95% CI: 2.54-10.35) compared to the non-very-high-risk group. Their 1-, 2-, and 5-year mortality rates were 28.87%, 47.18%, and 82.42%, respectively, similar to GAP stage III but with narrower confidence intervals.
Conclusion: This study developed a prognostic model for F-ILD combining PROMs and functional exercise data. The model, which includes the SGRQ, 6MWD, and 1MSTS, outperforms GAP staging, offering benefits like reduced patient fatigue and improved monitoring. Multicenter studies are needed to validate these findings.
Trial registration: The study was registered on ClinicalTrials.gov (NCT06476470).
期刊介绍：
Respirology is a journal of international standing, publishing peer-reviewed articles of scientific excellence in clinical and clinically-relevant experimental respiratory biology and disease. Fields of research include immunology, intensive and critical care, epidemiology, cell and molecular biology, pathology, pharmacology, physiology, paediatric respiratory medicine, clinical trials, interventional pulmonology and thoracic surgery.
The Journal aims to encourage the international exchange of results and publishes papers in the following categories: Original Articles, Editorials, Reviews, and Correspondences.
Respirology is the preferred journal of the Thoracic Society of Australia and New Zealand, has been adopted as the preferred English journal of the Japanese Respiratory Society and the Taiwan Society of Pulmonary and Critical Care Medicine and is an official journal of the World Association for Bronchology and Interventional Pulmonology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
